Johnson & Johnson (JNJ)

144.600
+0.200(+0.14%)
  • Volume:
    0
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    144.100 - 144.600

JNJ Overview

Prev. Close
144.4
Day's Range
144.1-144.6
Revenue
96.26B
Open
144.1
52 wk Range
138.5-177.56
EPS
4.86
Volume
0
Market Cap
402.54B
Dividend (Yield)
4.76
(2.92%)
Average Volume (3m)
48
P/E Ratio
31.83
Beta
0.534
1-Year Change
-13.65%
Shares Outstanding
2,797,468,519
Next Earnings Date
-
What is your sentiment on J&J?
or
Market is currently closed. Voting is open during market hours.

Johnson & Johnson Company Profile

Johnson & Johnson Company Profile

Employees
152700
  • Type:Equity
  • Market:Austria
  • ISIN:US4781601046

Johnson & Johnson is a diversified healthcare products company. The Company is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer Health, Pharmaceutical and MedTech. Its primary focus is products related to human health and well-being. The Consumer Health segment includes a range of products that is focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The MedTech segment includes a range of products used in the interventional solutions, orthopaedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellNeutral
Technical IndicatorsStrong SellStrong Sell
SummaryStrong SellSell
  • Niceee movement
    0
    • Interest rates?
      0
      • FDA approved finally. Few minutes ago!!!!
        0
        • What?
          0
      • Invested in J&J a couples years back and have closely followed the pharmaceutical industry. Found a company by the name of SpectrumX which has an IPO set for November. SpectrumX are leaders in patented shielded HOCL formulations that have numerous applications in medical/pharma fields. They have also undergone 2 clinical trails for Covid-19 treatment (apparently not factored into the company valuation.) To me this company seems to be on track for high growth after the IPO, however I may be getting lost in the hype. Would love to hear people's thoughts on the stock as I am keen to invest early.
        0
        • To entry in Spectrum or not? What do you think?
          0
        • Checking it out looks like a good punt
          0
      • Good job JNJ. move forward bullish
        0
        • Stock split???
          0
          • Where we go next?
            0
            • AMC! But ultimately it’s your decision.
              0
          • Good buy. 0at this price
            0
            • JNJ is going to Make a strong come back tonight!
              1
              • Immediate inquiry must be done
                4